Roundtable on Black in cancer research and oncology
Brandon Blue, Kilan Ashad-Bishop, Onyinye and Folu Balogun and Runcie C.W. Chidebe
Summary (AI generated)
And so, what we were able to see is that the access to these new therapies for people unfortunately created an issue, as it was not standardized across the board. Not everyone who had this new emerging novel way of treating cancer had access to it. Unfortunately, this is something we are trying to change.
To evaluate this, one of the things we did that we are very proud of is sending questionnaires to some oncologists here in the State of Florida. We asked them if they send people to Cart, and if not, why not. Through our research, we found that doctors who were less likely to understand Cart and how to take care of Cart were also less likely to send people for it.
It is important for people to know that once they come to us for Cart, they don't stay as a Cart patient. They do go back to their community, and their local doctor is typically able to take care of them.